Oncternal Therapeutics, Inc. Quarterly Operating Income (Loss) in USD from Q2 2010 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Oncternal Therapeutics, Inc. quarterly/annual Operating Income (Loss) history and growth rate from Q2 2010 to Q3 2024.
  • Oncternal Therapeutics, Inc. Operating Income (Loss) for the quarter ending September 30, 2024 was -$8.68M, a 16.4% increase year-over-year.
  • Oncternal Therapeutics, Inc. Operating Income (Loss) for the twelve months ending September 30, 2024 was -$36M, a 18.3% increase year-over-year.
  • Oncternal Therapeutics, Inc. annual Operating Income (Loss) for 2023 was -$41.7M, a 7.19% increase from 2022.
  • Oncternal Therapeutics, Inc. annual Operating Income (Loss) for 2022 was -$44.9M, a 43.3% decline from 2021.
  • Oncternal Therapeutics, Inc. annual Operating Income (Loss) for 2021 was -$31.4M, a 78.8% decline from 2020.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$36M -$8.68M +$1.71M +16.4% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-06
Q2 2024 -$37.7M -$8.86M +$682K +7.15% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-08
Q1 2024 -$38.4M -$8.78M +$3.36M +27.7% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-09
Q4 2023 -$41.7M -$9.64M +$2.28M +19.1% Oct 1, 2023 Dec 31, 2023 10-K 2024-03-07
Q3 2023 -$44M -$10.4M +$935K +8.26% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-06
Q2 2023 -$44.9M -$9.55M +$2.25M +19.1% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-08
Q1 2023 -$47.2M -$12.1M -$2.23M -22.5% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-09
Q4 2022 -$44.9M -$11.9M -$3.84M -47.5% Oct 1, 2022 Dec 31, 2022 10-K 2024-03-07
Q3 2022 -$41.1M -$11.3M -$1.69M -17.5% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-09
Q2 2022 -$39.4M -$11.8M -$4.11M -53.4% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-10
Q1 2022 -$35.3M -$9.91M -$3.95M -66.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 -$31.4M -$8.08M -$5.22M -182% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-09
Q3 2021 -$26.1M -$9.64M -$5.24M -119% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 -$20.9M -$7.69M -$2.16M -38.9% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-09
Q1 2021 -$18.8M -$5.96M -$1.21M -25.4% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q4 2020 -$17.5M -$2.86M +$1.32M +31.6% Oct 1, 2020 Dec 31, 2020 10-K 2022-03-10
Q3 2020 -$18.9M -$4.4M +$554K +11.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q2 2020 -$19.4M -$5.54M +$16.1M +74.4% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-05
Q1 2020 -$35.5M -$4.75M -$2.39M -101% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-06
Q4 2019 -$33.1M -$4.18M +$1.41M +25.2% Oct 1, 2019 Dec 31, 2019 10-K/A 2021-03-12
Q3 2019 -$34.5M -$4.95M -$3.02M -156% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-04
Q2 2019 -$31.5M -$21.6M -$19.1M -751% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-06
Q1 2019 -$12.4M -$2.36M +$11.3M +82.8% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-07
Q4 2018 -$23.7M -$5.59M +$3.81M +40.6% Oct 1, 2018 Dec 31, 2018 10-K 2019-03-18
Q3 2018 -$27.6M -$1.93M +$6.6M +77.3% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-08
Q2 2018 -$34.2M -$2.54M +$3.9M +60.6% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-09
Q1 2018 -$38.1M -$13.7M -$7.41M -118% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q4 2017 -$30.7M -$9.4M -$2.54M -36.9% Oct 1, 2017 Dec 31, 2017 10-K 2019-03-18
Q3 2017 -$28.1M -$8.53M -$1.6M -23.2% Jul 1, 2017 Sep 30, 2017 10-K 2019-03-18
Q2 2017 -$26.5M -$6.45M -$388K -6.41% Apr 1, 2017 Jun 30, 2017 10-K 2019-03-18
Q1 2017 -$26.1M -$6.28M -$195K -3.21% Jan 1, 2017 Mar 31, 2017 10-K 2019-03-18
Q4 2016 -$25.9M -$6.86M -$906K -15.2% Oct 1, 2016 Dec 31, 2016 10-K 2018-03-13
Q3 2016 -$25M -$6.93M -$1.06M -18.1% Jul 1, 2016 Sep 30, 2016 10-K 2018-03-13
Q2 2016 -$24M -$6.06M -$1.1M -22.1% Apr 1, 2016 Jun 30, 2016 10-K 2018-03-13
Q1 2016 -$22.9M -$6.09M -$1.03M -20.3% Jan 1, 2016 Mar 31, 2016 10-K 2018-03-13
Q4 2015 -$21.8M -$5.96M -$501K -9.18% Oct 1, 2015 Dec 31, 2015 10-K 2017-03-24
Q3 2015 -$21.3M -$5.86M -$907K -18.3% Jul 1, 2015 Sep 30, 2015 10-K 2017-03-24
Q2 2015 -$20.4M -$4.96M +$5.99M +54.7% Apr 1, 2015 Jun 30, 2015 10-K 2017-03-24
Q1 2015 -$26.4M -$5.06M +$3.93M +43.7% Jan 1, 2015 Mar 31, 2015 10-K 2017-03-24
Q4 2014 -$30.3M -$5.46M +$3.72M +40.5% Oct 1, 2014 Dec 31, 2014 10-K 2016-03-15
Q3 2014 -$34.1M -$4.96M +$4M +44.7% Jul 1, 2014 Sep 30, 2014 10-K 2016-03-15
Q2 2014 -$38.1M -$10.9M +$1.88M +14.6% Apr 1, 2014 Jun 30, 2014 10-K 2016-03-15
Q1 2014 -$40M -$8.99M +$3.65M +28.9% Jan 1, 2014 Mar 31, 2014 10-K 2016-03-15
Q4 2013 -$43.6M -$9.18M +$3.73M +28.9% Oct 1, 2013 Dec 31, 2013 10-K 2015-03-16
Q3 2013 -$47.3M -$8.96M +$3.8M +29.8% Jul 1, 2013 Sep 30, 2013 10-K 2015-03-16
Q2 2013 -$51.1M -$12.8M -$1.19M -10.2% Apr 1, 2013 Jun 30, 2013 10-K 2015-03-16
Q1 2013 -$49.9M -$12.6M -$214K -1.72% Jan 1, 2013 Mar 31, 2013 10-K 2015-03-16
Q4 2012 -$49.7M -$12.9M -$905K -7.54% Oct 1, 2012 Dec 31, 2012 10-K 2014-03-12
Q3 2012 -$48.8M -$12.8M -$1.87M -17.2% Jul 1, 2012 Sep 30, 2012 10-K 2014-03-12
Q2 2012 -$47M -$11.6M -$1.07M -10.1% Apr 1, 2012 Jun 30, 2012 10-K 2014-03-12
Q1 2012 -$45.9M -$12.4M -$9.99M -410% Jan 1, 2012 Mar 31, 2012 10-K 2014-03-12
Q4 2011 -$35.9M -$12M Oct 1, 2011 Dec 31, 2011 10-K 2013-03-05
Q3 2011 -$10.9M -$2.31M -26.9% Jul 1, 2011 Sep 30, 2011 10-K 2013-03-05
Q2 2011 -$10.6M +$2.43M +18.7% Apr 1, 2011 Jun 30, 2011 10-K 2013-03-05
Q1 2011 -$2.44M Jan 1, 2011 Mar 31, 2011 10-K 2013-03-05
Q3 2010 -$8.58M Jul 1, 2010 Sep 30, 2010 10-Q 2011-11-04
Q2 2010 -$13M Apr 1, 2010 Jun 30, 2010 10-Q 2011-08-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.